Please join us for a Foley Executive Briefing Series seminar exploring the mysterious world of angel financing.
- Who are these angels and how do you find them?
- Are there different types of angels suitable for different types of ventures?
- What are angels looking for from prospective investment opportunities?
- What do you get from angels other than money?
- What are the pros and cons of bringing angels into your venture?
- How does angel financing impact your valuation and future funding prospects?
- How should the investment be structured? How does an experienced entrepreneur view angels?
These and other questions will be addressed in an informal, interactive panel session led by Gabor Garai, Chair of Foley’s Private Equity & Venture Capital Practice and Co-Chair of the Life Sciences Industry Team. Panel members will include Chris Sheehan, Managing Director of Common Angels and founder of an angel-funded company and Bob Buderi, Founder, CEO, and Editor in Chief of Xconomy.
Finding Your Angel: All You Ever Wanted to Know About Angel Financing is part of the Foley Executive Briefing Series. Learn more about upcoming programs in the series at Foley.com/FEBS.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.